Table 1 of Nikolaeva, Mol Vis 2019; 25:400-414.


Table 1. The basic parameters of photoresponses presented as ratios of post- and pretreated values, obtained in “outer segment out” configuration in Ringer’s solution and after 20 min incubation in drug-containing solution (mean ± SEM); * denotes p < 0.05 versus control, & denotes p < 0.05 versus 0.1% DMSO control.

  Light sensitivity Aсtivation rate (A) Turn-off time constant (τoff) Dark current Dominant recovery time constant (τD)
Control 0.99±0.04 0.75±0.06 1.01±0.05 1.06±0.04 1.01±0.05
  (n=10) (n=10) (n=10) (n=10) (n=10)
           
Dopamine (0.1 µM) 0.9±0.06 0.89±0.12 0.83±0.07 0.95±0.04 1.11±0.07
  (n=12) (n=12) (n=12) (n=12) (n=11)
           
Dopamine 0.74±0.07 0.72±0.07 0.97±0.14 1.02±0.07 1.04±0.04
(2.5 µM) (n=10) * (n=10) (n=10) (n=10) (n=9)
           
Dopamine (20 µM) 0.66±0.06 0.57±0.10 0.8±0.11 0.99±0.04 0.92±0.08
  (n=9) * (n=9) (n=9) (n=9) (n=8)
Dopamine (50 µM) 0.71±0.04 0.56±0.10 0.66±0.05 1.05±0.02 0.89±0.06
  (n=7) * (n=7) (n=7) (n=7) (n=7)
SKF-38,393 0.74±0.04 0.83±0.05 0.90±0.06 1.03±0.02 0.87±0.06
(0.1 µM) (n=10) * (n=10) (n=10) (n=10) (n=10)
           
SKF-38393 0.77±0.04 0.76±0.07 0.93±0.05 1.07±0.03 0.83±0.05
(2.5 µM) (n=9) * (n=9) (n=9) (n=9) (n=9)
           
SKF-38393 0.62±0.05 0.60±0.05 0.72±0.06 1.00±0.02 0.75±0.04
(20 µM) (n=10) * (n=10) (n=10) * (n=10) (n=10) *
           
SKF-38393 0.58±0.08 0.47±0.11 0.64±0.07 1.07±0.04 0.62±0.03
(50 µM) (n=9) * (n=9) (n=9) * (n=9) (n=8) *
           
Quinpirole (2.5 µM) 0.86±0.09 0.85±0.07 1.05±0.11 1.05±0.03 0.98±0.08
  (n=9) (n=9) (n=9) (n=9) (n=8)
Quinpirole (20 µM) 0.85±0.08 0.71±0.05 0.96±0.06 1.05±0.03 0.94±0.04
  (n=10) (n=10) (n=10) (n=10) (n=9)
Quinpirole (50 µM) 0.74±0.02 0.68±0.05 0.82±0.05 1.11±0.06 0.95±0.03
  (n=11) * (n=11) (n=11) (n=11) (n=11)
Control 1.00±0.03 1.11±0.08 1.08±0.10 1.03±0.02 1.11±0.04
(0.1% DMSO) (n=5) (n=5) (n=5) (n=5) (n=5)
           
SKF-83959 0.73±0.02 0.97±0.07 0.78±0.03 1.05±0.03 1.01±0.07
(50 µM) (n=10) & (n=10) (n=10) & (n=10) (n=5)